Clinical Trial 8027

Grapevine, TX 76051


Study Summary:

We are looking for patients who have been diagnosed with stage 1-4 cancer that are using IPTLD (Insulin Potentiation Targeted LowDose Chemotherapy) and Nutritional Therapy for treatment to participate in this Quality of Life study. This is an investigational study designed to determine the impact of IPTLD and nutritional therapy upon patients’ Quality of Life (QoL). QoL is measured by questionnaires completed by the patient that rate mood, energy level, ability to function, level of pain, and other elements of their daily living. Patients will complete surveys once per month during their treatment, and then a series of follow-up surveys: every two months the second year; every three months the third year and every six months the fourth and fifth year. Won’t you please consider participation in this investigation?


Qualified Participants Must:

• Have stage I-IV (1-4) Cancer - any type
• Have declined conventional chemotherapy
• Have notified your oncologist & primary physician
• Have selected a treatment plan of targeted low dose chemotherapy & nutritional therapy
• Consent to Insulin Potentiation Targeted Lowdose Therapy (IPTLD) with Nutritional Therapy as primary treatment


Qualified Participants May Receive:

Participants will receive $100 gift cards each year.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.